Reader Picks: 2016’s Top Stories

Author(s):

Rheumatology Network Staff

The ACR workforce study, options for methotrexate, safe doses for glucocorticoids, the value of vitamin D supplements, the dangers of chikungunya, and new treatments for giant cell arteritis were among our most popular stories this year. Here's a quick look back at 2016.

The ACR workforce study, options for methotrexate, safe doses for glucocorticoids, the value of vitamin D supplements, the dangers of chikungunya, and new treatments for giant cell arteritis were among our most popular stories this year. Here's a quick look back at 2016. 

Related Videos
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Allysa Saggese, NP | Credit: Weill Cornell Medicine
Zobair Younossi, MD, MPH | Credit: American College of Gastroenterology
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Related Content
Sanghyuk Seo, former manager, Real-World Value and Evidence, Neuroscience, Janssen,
October 11th 2024

Highly Beneficial Antipsychotics Underutilized in People With Schizophrenia

Victoria Johnson
Taher Modarressi, MD | Credit: X.com
October 3rd 2024

Don't Miss a Beat: Putting Evidence-Based Cardiometabolic Therapies into Practice, with Taher Modarressi, MD

Muthiah Vaduganathan, MD, MPH Stephen Greene, MD
| Image Credit: Chris Robert/Unsplash
October 10th 2024

Short-Term Surge in Air Pollution May Trigger Schizophrenia Episodes

Connor Iapoce
MEDCast Podcast logo
October 1st 2024

Exploring Oral Systemic Therapies for Plaque Psoriasis: Efficacy, Safety, and Clinical Considerations

Lauren Miller, MPAS, PA-C Jayme M Heim, MSN, FNP-BC Kirk Gautier, PA-C
Aleksi Hamina, PhD | Credit: LinkedIn
October 10th 2024

Paliperidone 3-Month LAI Bests Other Antipsychotics for Preventing Relapse, Treatment Failure in Schizophrenia

Patrick Campbell
Stronger Safety Considerations Needed for Lumateprone Use, Especially for Women
October 10th 2024

Stronger Safety Considerations Needed for Lumateprone Use, Especially for Women

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.